Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) reported that Chief Financial Officer Jerome Wong purchased 1,308 shares of common stock on March 16, 2026. The transaction was executed at $11.85 per share, bringing the total value of the purchase to $15,499.
According to the filing, those shares were acquired indirectly through the company’s 401(k) contribution matching program. Following the acquisition, Wong is listed as directly holding 24,771 shares of Ekso Bionics common stock and indirectly holding an additional 4,184 shares.
The company’s shares are trading at $10.54, and have returned 56% over the past year, despite an 8.8% decline in the past week.
Analyst tools and valuation notes
An InvestingPro analysis cited in the filing indicates the stock is currently overvalued. The note references seven additional ProTips available to subscribers, including material on the company’s cash burn rate and ongoing profitability challenges.
Recent corporate developments
In other filings, Ekso Bionics revealed a private placement agreement valued at approximately $5.9 million. The transaction contemplates the sale of 5,852 shares of Series B Preferred Stock at a stated value of $1,000 per share, together with warrants enabling purchase of up to 355,960 shares of common stock.
Separately, Ekso Bionics has entered a non-binding merger agreement with Applied Digital Cloud intended to create a new entity named ChronoScale Corporation, focused on artificial intelligence workloads. Under the proposed terms, Applied Digital would own about 97% of the combined company. The merger is anticipated to close in the first half of 2026, subject to required approvals.
Following the announcement of the merger terms, H.C. Wainwright adjusted its coverage stance, downgrading Ekso Bionics’ rating from Buy to Neutral.
These transactions and strategic moves mark a period of notable change for Ekso Bionics as the company pursues new financing and a potential combination with Applied Digital Cloud while monitoring valuation and operating performance metrics highlighted by analyst tools.